APO Research

APO RESEARCH · REPORT

Quinolones

Selected research

Market Structure

Global Quinolones Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Quinolones market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Quinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Quinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Quinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Quinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Quinolones include Sanofi, Johnson & Johnson, Novartis, Merck, Bayer, LG Corporation and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Quinolones market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Quinolones and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Quinolones sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quinolones market size, projected growth trends, production technologies, key applications, and end-use industries.

Quinolones Segment by Company

Sanofi

Johnson & Johnson

Novartis

Merck

Bayer

LG Corporation

Allergan

Quinolones Segment by Type

Ciprofloxacin

Gemifloxacin

Norfloxacin

Ofloxacin

Others

Quinolones Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Quinolones Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quinolones market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quinolones and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quinolones.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quinolones market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Quinolones manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Quinolones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Quinolones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Quinolones Industry Trends Table 2. Quinolones Industry Drivers Table 3. Quinolones Industry Opportunities and Challenges Table 4. Quinolones Industry Restraints Table 5. Global Quinolones Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Quinolones Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Quinolones Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Quinolones Sales Market Share by Manufacturers Table 9. Global Quinolones Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Quinolones Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Quinolones Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Quinolones Manufacturers, Product Type & Application Table 13. Global Quinolones Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Quinolones by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ciprofloxacin Table 17. Major Manufacturers of Gemifloxacin Table 18. Major Manufacturers of Norfloxacin Table 19. Major Manufacturers of Ofloxacin Table 20. Major Manufacturers of Others Table 21. Global Quinolones Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Quinolones Sales by Type (2021-2026) & (K Units) Table 23. Global Quinolones Sales by Type (2027-2032) & (K Units) Table 24. Global Quinolones Sales Market Share by Type (2021-2026) Table 25. Global Quinolones Sales Market Share by Type (2027-2032) Table 26. Global Quinolones Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Quinolones Revenue by Type (2021-2026) & (K Units) Table 28. Global Quinolones Revenue by Type (2027-2032) & (K Units) Table 29. Global Quinolones Revenue Market Share by Type (2021-2026) Table 30. Global Quinolones Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Retail Pharmacies Table 32. Major Manufacturers of Online Pharmacies Table 33. Major Manufacturers of Hospital Pharmacies Table 34. Global Quinolones Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Quinolones Sales by Application (2021-2026) & (K Units) Table 36. Global Quinolones Sales by Application (2027-2032) & (K Units) Table 37. Global Quinolones Sales Market Share by Application (2021-2026) Table 38. Global Quinolones Sales Market Share by Application (2027-2032) Table 39. Global Quinolones Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Quinolones Revenue by Application (2021-2026) & (K Units) Table 41. Global Quinolones Revenue by Application (2027-2032) & (K Units) Table 42. Global Quinolones Revenue Market Share by Application (2021-2026) Table 43. Global Quinolones Revenue Market Share by Application (2027-2032) Table 44. Global Quinolones Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Quinolones Sales by Region (2021-2026) & (K Units) Table 46. Global Quinolones Sales Market Share by Region (2021-2026) Table 47. Global Quinolones Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Quinolones Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Quinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Quinolones Sales by Country (2021-2026) & (K Units) Table 51. North America Quinolones Sales by Country (2027-2032) & (K Units) Table 52. Europe Quinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Quinolones Sales by Country (2021-2026) & (K Units) Table 54. Europe Quinolones Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Quinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Quinolones Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Quinolones Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Quinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Quinolones Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Quinolones Sales by Country (2027-2032) & (K Units) Table 61. Global Quinolones Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Quinolones Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Quinolones Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Quinolones Revenue Market Share by Region (2021-2026) Table 65. Global Quinolones Revenue Market Share by Region (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Quinolones Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sanofi Quinolones Product Portfolio Table 70. Sanofi Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Quinolones Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Quinolones Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Quinolones Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Novartis Quinolones Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Quinolones Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Merck Quinolones Product Portfolio Table 85. Merck Recent Development Table 86. Bayer Company Information Table 87. Bayer Business Overview Table 88. Bayer Quinolones Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Bayer Quinolones Product Portfolio Table 90. Bayer Recent Development Table 91. LG Corporation Company Information Table 92. LG Corporation Business Overview Table 93. LG Corporation Quinolones Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. LG Corporation Quinolones Product Portfolio Table 95. LG Corporation Recent Development Table 96. Allergan Company Information Table 97. Allergan Business Overview Table 98. Allergan Quinolones Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Allergan Quinolones Product Portfolio Table 100. Allergan Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Quinolones Distributors List Table 104. Quinolones Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Quinolones Product Image Figure 2. Global Quinolones Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quinolones Market Size (2021-2032) & (US$ Million) Figure 4. Global Quinolones Sales (2021-2032) & (K Units) Figure 5. Global Quinolones Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Quinolones Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ciprofloxacin Image Figure 9. Gemifloxacin Image Figure 10. Norfloxacin Image Figure 11. Ofloxacin Image Figure 12. Others Image Figure 13. Global Quinolones Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Quinolones Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Quinolones Sales Market Share by Type (2021-2032) Figure 16. Global Quinolones Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Quinolones Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Quinolones Revenue Market Share by Type (2021-2032) Figure 19. Retail Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Hospital Pharmacies Image Figure 22. Global Quinolones Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Quinolones Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Quinolones Sales Market Share by Application (2021-2032) Figure 25. Global Quinolones Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Quinolones Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Quinolones Revenue Market Share by Application (2021-2032) Figure 28. North America Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Quinolones Sales Market Share by Country (2021-2032) Figure 30. U.S. Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Quinolones Sales Market Share by Country (2021-2032) Figure 35. Germany Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Quinolones Sales Market Share by Country (2021-2032) Figure 42. China Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Quinolones Sales Market Share by Country (2021-2032) Figure 50. Brazil Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Quinolones Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Quinolones Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Quinolones Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Quinolones Revenue (2021-2032) & (US$ Million) Figure 61. North America Quinolones Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Quinolones Revenue (2021-2032) & (US$ Million) Figure 63. Europe Quinolones Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Quinolones Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Quinolones Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Quinolones Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Quinolones Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Quinolones Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Quinolones Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Ciprofloxacin
  • Gemifloxacin
  • Norfloxacin
  • Ofloxacin
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Bayer
  • LG Corporation
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Quinolones Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Quinolones Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Quinolones Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Quinolones Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Quinolones Market Dynamics
  1. 2.1 Quinolones Industry Trends
  2. 2.2 Quinolones Industry Drivers
  3. 2.3 Quinolones Industry Opportunities and Challenges
  4. 2.4 Quinolones Industry Restraints
3 Quinolones Market by Manufacturers
  1. 3.1 Global Quinolones Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Quinolones Sales by Manufacturers (2021-2026)
  3. 3.3 Global Quinolones Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Quinolones Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Quinolones Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Quinolones Manufacturers, Product Type & Application
  7. 3.7 Global Quinolones Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Quinolones Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Quinolones Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Quinolones Tier 1, Tier 2, and Tier 3
4 Quinolones Market by Type
  1. 4.1 Quinolones Type Introduction
  2. 4.1.1 Ciprofloxacin
  3. 4.1.2 Gemifloxacin
  4. 4.1.3 Norfloxacin
  5. 4.1.4 Ofloxacin
  6. 4.1.5 Others
  7. 4.2 Global Quinolones Sales by Type
  8. 4.2.1 Global Quinolones Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Quinolones Sales by Type (2021-2032)
  10. 4.2.3 Global Quinolones Sales Market Share by Type (2021-2032)
  11. 4.3 Global Quinolones Revenue by Type
  12. 4.3.1 Global Quinolones Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Quinolones Revenue by Type (2021-2032)
  14. 4.3.3 Global Quinolones Revenue Market Share by Type (2021-2032)
5 Quinolones Market by Application
  1. 5.1 Quinolones Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Quinolones Sales by Application
  6. 5.2.1 Global Quinolones Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Quinolones Sales by Application (2021-2032)
  8. 5.2.3 Global Quinolones Sales Market Share by Application (2021-2032)
  9. 5.3 Global Quinolones Revenue by Application
  10. 5.3.1 Global Quinolones Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Quinolones Revenue by Application (2021-2032)
  12. 5.3.3 Global Quinolones Revenue Market Share by Application (2021-2032)
6 Global Quinolones Sales by Region
  1. 6.1 Global Quinolones Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Quinolones Sales by Region (2021-2032)
  3. 6.2.1 Global Quinolones Sales by Region (2021-2026)
  4. 6.2.2 Global Quinolones Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Quinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Quinolones Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Quinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Quinolones Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Quinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Quinolones Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Quinolones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Quinolones Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Quinolones Revenue by Region
  1. 7.1 Global Quinolones Revenue by Region
  2. 7.1.1 Global Quinolones Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Quinolones Revenue by Region (2021-2026)
  4. 7.1.3 Global Quinolones Revenue by Region (2027-2032)
  5. 7.1.4 Global Quinolones Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Quinolones Revenue (2021-2032)
  8. 7.2.2 North America Quinolones Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Quinolones Revenue (2021-2032)
  11. 7.3.2 Europe Quinolones Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Quinolones Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Quinolones Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Quinolones Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Quinolones Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Quinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Quinolones Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Quinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Quinolones Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Quinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Quinolones Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Quinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Quinolones Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Quinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Quinolones Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 LG Corporation
  32. 8.6.1 LG Corporation Company Information
  33. 8.6.2 LG Corporation Business Overview
  34. 8.6.3 LG Corporation Quinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LG Corporation Quinolones Product Portfolio
  36. 8.6.5 LG Corporation Recent Developments
  37. 8.7 Allergan
  38. 8.7.1 Allergan Company Information
  39. 8.7.2 Allergan Business Overview
  40. 8.7.3 Allergan Quinolones Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Allergan Quinolones Product Portfolio
  42. 8.7.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Quinolones Value Chain Analysis
  2. 9.1.1 Quinolones Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Quinolones Production Mode & Process
  6. 9.2 Quinolones Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Quinolones Distributors
  9. 9.2.3 Quinolones Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research